The mechanism by which B1a cells protect against atherosclerosis is by secreting protective natural IgM antibodies capable of neutralizing oxidized low-density lipoproteins and targeting leukocytes and T cells. 5, 8 However, the mechanisms by which follicular B (FO B) cells promote atherosclerosis are not known.
Conventional B cells can in principle promote atherosclerosis by at least 3 different mechanisms: secreting proinflammatory cytokines; antigen presentation to T cells, including naïve T cells; and also differentiating into plasma cells producing immunoglobulins. Effector B2 B cells primed by Th1 cells and antigens secrete proinflammatory/proatherogenic cytokines, including TNF-α (tumor necrosis factor-α), IFN-γ (interferon-γ), and IL (interleukin)-12, while those primed by Th2 cells and antigens secrete IL-2 and IL-4, 9 cytokines implicated in atherosclerosis. B cell-derived TNF-α is a relatively minor contributor to atherosclerosis.
10 B2 cells also express major histocompatibility II (MHCII) and CD1d and, thus, can act as peptide and lipid antigen presenting cells affecting CD4 T cells and NKT (natural killer T) cells. 11, 12 B cell-mediated e72
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antigen presentation contributes to pathogenic mechanisms implicated in acute allograft rejection 14, 15 Several lines of evidence implicate humoral B cell immune responses in the pathogenesis of atherosclerosis. Antibodies to hsp65 (heat-shock protein 65) have been associated with severe carotid atherosclerosis in humans. 16 Furthermore, autoantibodies against hsp65 promote atherosclerosis via mechanisms dependent on endothelial cell damage. 17 More recently, pathogenic roles for modified low-density lipoprotein antibodies in atherosclerosis have been suggested. 18 However, despite such studies, definitive evidence for FO B cell-dependent humoral mechanisms, including a role for IgG contributing to development of atherosclerosis, is lacking. 4 Here using both loss and gain of function studies, we provide compelling evidence that FO B cells promote development of atherosclerosis via mechanisms dependent on their expression of MHCII and CD40. Mixed chimeric Ldlr −/− mice whose B cells were deficient in MHCII or CD40, molecules essential for the interaction of FO B cells with CD4 + Tfh cells exhibited greatly reduced atherosclerotic lesions associated with large reductions in IgG. We used chimeric mice whose FO B cells are deficient in Blimp-1 (B-lymphocyte-induced maturation protein), a transcription factor required for FO B cell differentiation into plasma cells 19 to demonstrate that FO B cells promote atherosclerosis by differentiating to plasma cells. A critical role for IgG in promoting atherosclerosis was demonstrated by transferring IgG purified from atherosclerotic mice into chimeric Ldlr −/− mice whose FO B cells were deficient in Blimp-1.
Materials and Methods

Ethics and Animals
All animal experiments complied with national guidelines for care and use of laboratory animals and approved by the Animal Ethics Committee of the Alfred Medical Research and Education Precinct, Melbourne, Australia. All mice were on a C57Bl6 genetic background. B cell-deficient (µMT −/− ) mice were maintained at Monash Medical Center Animal Facilities, Clayton, Australia. Wild-type (C57Bl6) mice, apolipoprotein E-deficient (Apoe Cd23-Cre mice were bred at the Walter and Eliza Hall Institute, Melbourne, and generated by crossing Cd23-Cre mice 21 with Blimp-1 fl/fl mice. 22 We chose male mice in our study because virtually all previous studies on B cells and atherosclerosis used male mice; thus, we cannot exclude possible gender-dependent effects. All animal experiments were conducted at Precinct Animal Center, Animal Ethics Committee of the Alfred Medical Research and Education Precinct. Atherosclerosis was induced by feeding a high fat diet containing 21% fat and 0.15% cholesterol (HFD; Specialty Feeds, Glen Forrest, Western Australia) for 8 weeks. Sterile water was given ad libitum throughout the experiment.
Generation of Bone Marrow Chimeric Ldlr
−/− Mice With B Cell Deficient in MHCII, CD40, and Blimp-1
Bone marrow (BM) transplantation using Ldlr −/− mice as recipients is a widely accepted and frequently used technology for altering specific genes in atherosclerotic mice 23, 24 and in some instances exhibits advantages over cross-breeding. 25 We used a mixed chimera BM transplantation approach to delete CD40 and MHCII from B cells. 10, 26 Briefly, 6-week-old male Ldlr −/− mice were subjected to whole-body irradiation with 10 Gy in 2 divided doses at 4 hourly intervals, followed by tail vein injection of 5 million BM cells comprising 80% from either µMT mice or wild-type mice and 20% from either Cd40 Cd23-Cre mice. Four weeks later when BM is fully reconstituted, the different chimeric mice were given ad libitum a HFD for 8 weeks.
Tissue Collection
Both experimental and donor mice were killed by using slow-fill carbon dioxide asphyxiation. Male donor mice were used to isolate BM cells from femur and tibia bones for transplantation into irradiated Ldlr −/− mice. After culling experimental mice blood was collected via cardiac puncture, the spleen for fluorescence-activated cell sorter (FACS) analyses, and hearts for assessment of atherosclerosis at the aortic root after embedding in optimal cutting temperature compound and freezing at −80°C. Blood was also collected for isolation and purification of IgG from atherosclerotic Apoe −/− (HFD for 23 weeks) and wild-type C57Bl6 mice.
IgG Purification
Plasma IgG purification was performed using affinity chromatography. Briefly, plasma samples from Chow-fed C57Bl/6 mice or HFD-Apoe −/− mice were pooled, diluted 4-fold in phosphate-buffered saline, filtered through 0.45 μmol/L filter, and loaded onto a HiTrap Protein G HP column (GE) using BioLogic DuoFlow Medium 
Plasma Lipids
Plasma concentrations of total cholesterol and very low-density lipoprotein/low-density lipoprotein cholesterol were determined enzymatically using a cholesterol assay kit (Roche/Hitachi) and automated chemistry analyzer.
7
Flow Cytometry
Immune cells in peripheral blood and spleen were analyzed with fluorochrome conjugated antibodies (BD Pharmingen, San Diego, CA) on FACS-Canto II (BD Biosciences) as previously described. 7 Anti-CD19, anti-CD5, anti-IgM, anti-IgD, anti-CD23, anti-CD21, anti-CD1d, anti-MHCII, anti-CD11c, anti-CD11b, anti-CD44, anti-CD138, anti-IgD, anti-GL7, anti-CD4, anti-CD8, anti-TCR (T-cell receptor)-β, and anti-NK1.1 Abs were used in immune cell analysis. In intracellular staining, cells were stimulated for 5 to 6 hours with Cell Stimulation Cocktail plus Protein Transport Inhibitors (eBioscience, San Diego, CA). After blocking Fc receptors, surface markers were first stained with anti-TCR-β, anti-CD4, and anti-CD8 antibodies. 
Atherosclerosis Assessment
In accordance with the American Heart Association statement, 27 frozen sections (6 μm) were cut from optimal cutting temperature compound-embedded aortic sinus, defined as the region where the valve or valve cusps first become visible to where the left and right coronary arteries branch off. For each mouse, intimal lesion areas were measured in 6 sequential cross-sectional areas at 80 μm intervals and averaged. 7 Total intimal lesion areas were measured in sections stained with hematoxylin and eosin; oil red-O-stained lipids within lesions were also quantified in a blinded manner using light microscopy imaging, Optimus 6.2 Video Pro-32 software, and a FVII Olympus camera. 7 For lesion necrotic core assessment, sections were stained with hematoxylin and eosin to identify acellular areas as necrotic cores and measured as described previously. 28 Apoptotic cells identified by terminal dUTP nick end-labeling under light microscopy were expressed per lesion areas as described before.
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Immunofluorescence
Frozen sections from atherosclerotic lesions were stained with appropriate nonimmune IgGs, anti-TNF-α, anti-IL-1β, anti-RANTES (regulated on activation, normal T-cell expressed and secreted), and anti-MCP-1 (monocyte chemotactic protein 1) antibodies as previously described. 28 Images were visualized under Olympus BX61 fluorescence microscope and images captured using FVII Olympus camera.
Enzyme-Linked Immunosorbent Assay
Plasma immunoglobulin (Ig) was determined using ELISA. Fifty microliter anti-mouse Ig (1 mg/mL) was used to coat 96-well ELISA plates overnight at 4°C. After blocking with 1% BSA, duplicate samples of 50 mL plasma (diluted 1:10 5 for total Ig and IgG and 1:10 4 for IgM) was added into ELISA plates for 2 hours at room temperature.
Respective secondary anti-mouse Abs conjugated with HRP were added into the wells, followed by addition of TMB substrate for color development. The OD at 450 nm was read by ELISA reader. 7 IL-1α and IL-6 ELISA kits (R&D systems) were used to determine the levels of these cytokines in affinity-purified plasma IgGs as per manufacturer's instructions.
Statistical Analysis
Statistical significance was assessed using a 2-tailed Student's t test or Mann-Whitney U test, depending on whether the data were normally distributed, as assessed by the Shapiro-Wilk test using GraphPad Prism program. Results were presented as mean±SEM. P values <0.05 were considered statistically significant.
Results
B Cell-Specific MHCII Expression Is Critical for the Proatherogenic Effects of FO B Cells
Tfh cell-dependent high affinity class switched antibody production is critically dependent on activated B cells presenting antigens to Tfh cells via MHCII. 29 To determine whether MHCII expression by FO B cells is critical for their proatherogenic effects, we generated mixed chimeric Ldlr −/− mice whose B cells were deficient in MHCII by transplanting BM from μMT chain-deficient mice or wild-type (WT) controls (80%) together with BM from mice deficient in MHCII (20%) into irradiated 6-week-old Ldlr −/− mice as previously described. 10, 26 This approach creates a control mouse model with B cells, the majority of which are competent in MHCII, and a test mouse model with MHCII −/− B cells that allows comparable reconstitution of non-B immune cells, such as macrophages, monocytes, dendritic cells, T cells all of which are crucially important in atherosclerosis pathogenesis (Table I in the online-only Data Supplement). Additional chimeric mice that received mixed BM cells (80% μMT-chain deficient BM and 20% WT BM) were also generated to serve as an additional control mouse model for mice with B cells selectively deficient in either MHCII or CD40 molecule (Table I in Figure 1G ), which was accompanied by a large (76%; P<0.05) reduction in splenic CD138 + plasma cells ( Figure 1H ). These effects were associated with large (>90%; P<0.05) reductions in plasma total Ig and IgG levels without affecting IgM levels ( Figure 1I) . B cells deficiency in MHCII did not affect lesion macrophages, CD3 T cells, CD19 B cells, or lesion collagen (Table II in CD40 is also required for upregulation of CD80/CD86 costimulatory molecules and subsequent T-cell stimulation. 36 As CD40 on FO B cells is activated by CD40L expressed by CD4 + Tfh cells, 37 we examined the effects on atherosclerosis of deleting CD40 from FO B cells in Ldlr −/− mice. We generated mixed chimeric Ldlr −/− mice by transplanting BM from μMT chain-deficient mice or WT controls (80%) together with BM from mice deficient in CD40 (20%) into irradiated 6-week-old Ldlr −/− mice as previously described, 10 as well as additional chimeric mice that received mixed BM cells (80% μMT chain-deficient BM and 20% WT BM; Table I in the online-only Data Supplement). These chimeric mice contain B cells with greatly reduced CD40 (Figure 2A ), and B cell-selective CD40 deficiency reduced atherosclerosis in aortic sinus compared with atherosclerotic lesions in the control, as well as in additional control mice ( Figure 2B Total body irradiation affects neointimal smooth muscle cells in blood vessels, as occurs after arterial injury rather than medial smooth muscle cells 38 ; neointimal smooth muscle which exhibit a synthetic phenotype and are highly proliferative differ from medial smooth muscle which exhibit a "contractile phenotype" and are quiescent. 39 To confirm that irradiation does not affect medial smooth muscle cells, the only smooth muscle cell type present in the aortic sinus of 6-week-old mice, we compared smooth muscle cells in medial layers in chimeric Ldlr −/− mice with B cells deficient in CD40 to HFD-fed ApoE and C57BL/6 mice that have not been exposed to total body irradiation. We did not see any effect of irradiation on vascular smooth muscles in both medial and intimal layers (Figure VII in the online-only Data Supplement).
FO B Cell Blimp-1 Deletion Prevents Development of Plasma Cells and Greatly Attenuates Atherosclerosis
Our studies suggest that IgGs produced by spleen plasma cells may be important in development of atherosclerosis. However, both MHCII and CD40 expression by B cells have the potential to stimulate naïve CD4 + T cells to some extent in addition to promoting humoral adaptive immunity. To directly assess the importance of adaptive humoral immunity independently of naïve CD4 + T cell stimulation, we generated chimeric mice whose B cells were deficient Figure 3A ). Activated spleen CD44 hi CD4+ and CD8+ T cell numbers were also unaffected (P>0.05; Figure 3B ). In contrast, plasma cell numbers were reduced by >90% ( Figure 3C ). Plasma total Ig and IgG levels were also reduced by >95%, while plasma IgM levels were reduced by nearly 80% (P<0.05; Figure 3D ). Critically, IgG in atherosclerotic lesions was undetectable ( Figure 3E) , and aortic lesion size was reduced by nearly 50% (P<0.05; Figure 3F and 3G). B cells' deficiency in Blimp-1 did not affect lesion macrophages, CD3 T cells, CD19 B cells, or l collagen (Table II in cytokines were detected was administered via tail-vein injection every 2 weeks. After 8 weeks, FACS analysis showed comparable numbers of FO B cells, but no plasma cells in spleens, findings similar to that in mice with Blimp-1-deficient B cells that we described earlier (data not shown). Resultant plasma IgG levels in the 2 groups of mice were similar (P>0.05; Figure 4B ), but Athero-IgG deposits accumulated to a much greater extent (≈7-fold) in atherosclerotic lesions than WT-IgG deposits (P<0.05; Figure 4C ). Furthermore, lesion size in mice receiving Athero-IgG increased 2.4-fold compared with those receiving WT-IgG (P<0.05; Figure 4D) ; plasma cholesterol levels are unaffected ( Figure 4E ). It is worthwhile to note that WT-IgG further reduced total lesion area ( Figure 4E ) compared with those in IgG-deficient mice, suggesting a possible protective role of nonatherosclerotic IgGs in accordance with the literature.
41,42
IgG From Atherosclerotic Mice Increases Lesion Cell Apoptosis, Necrotic Core Size and Inflammation
IgG immune complexes are known to activate complement and Fcγ receptors inducing apoptosis in target cells. 43, 44 As both systems have been implicated in atherosclerosis, 45, 46 we examined in gain and loss of function studies whether IgG produced during development of atherosclerosis affects lesion cell apoptosis and necrosis. After treatment with Athero-IgG lesion, apoptotic cell numbers doubled in Ldlr −/− mice whose FO B cells were deficient in Blimp-1 (P<0.05; Figure 5A , right). Athero-IgG also increased lesion necrotic core size, by 80% compared with WT-IgG (P<0.05; Figure 5B , right panel). To confirm these effects of Athero-IgG, we also assessed lesion apoptotic cell numbers and necrotic cores in Ldlr −/− mice whose B cells are deficient in Blimp-1, mice whose plasma IgG levels are reduced by 95% (Figure 3F and 3G) . In these mice lesion, apoptotic cells were reduced by nearly 53% (P<0.05; Figure 5C , right panel) and necrotic core size by 58%, respectively (P<0.05; Figure 5D , right panel), effects consistent with the Athero-IgG gain of function studies. As necrosis initiates release of HMGB1 (high-mobility group box 1 protein) 47 , a potent mediator of sterile inflammation, 48 which promotes atherosclerosis, 49 we examined whether Athero-IgG increases lesion proinflammatory cytokines. 
Discussion
Our study provides the definitive proof that the mechanisms by which FO B cells promote atherosclerosis are critically dependent on their differentiation to plasma cells. This is supported by our findings that the atherogenic effects of FO B cells are also highly dependent on their expression of MHCII and CD40, molecules required for B-T cell interactions and development of germinal center B cells, as well as Blimp-1, a transcriptional factor required for the differentiation of germinal center B cells to plasma cells (Figure 6 ). FO B cell differentiation to plasma cells seems to be the major mechanism by which FO B cells promote atherosclerosis, given that Blimp-1 deletion in these cells accounts for >80% of the proatherogenic effect of FO B cells on atherosclerosis, when compared with total B cell depletion. 7 Plasma cells seem to mediate their effects on atherosclerosis by producing pathogenic IgGs. Our results are consistent with the report that the Tfh-germinal center B-cell axis is proatherogenic. 50 Irradiation plus BM transplantation is a widely accepted method in studies on atherosclerosis used to delete specific molecules/cells from Ldlr −/− mice [23] [24] [25] but results in more rapid development of more inflamed lesions, 51 necessitating the use of appropriate controls. [23] [24] [25] As in other studies, [23] [24] [25] we also generated appropriate irradiated mixed chimeric controls for our comparative studies of the effects of MHCII, CD40, and Blimp-1 deletions from B cells. Our finding that the ability of FO B cells to promote atherosclerosis is dependent on their expression of MHCII is consistent with our observation that IgG from atherosclerotic mice promotes atherosclerosis. 31, 53 Deletion of MHCII on B cells markedly reduces germinal B cell numbers and plasma cells in the spleen, effects consistent with the large reductions in IgGs. Our finding that MHCII deletion on B cells exerts effects on atherosclerosis which are similar in magnitude to those observed with specific B cell deletion 54 indicates that MHCII expressed by FO B cells is a critically important mechanistic pathway by which B2 cells promote atherosclerosis.
The interaction of costimulatory molecules CD40 on FO B cells and CD40L on Tfh cells is also important for highaffinity antibody generation. CD40 expression by FO B cells is necessary for optimal primary B cell responses, including the generation of germinal centers, sustaining antibody production 55 and CD4 + Tfh cell formation. 56 After the large reductions in CD40 expression by B cells in the hyperlipidemic mice, atherosclerosis is also reduced but to a lesser extent than with MHCII deletion, consistent with CD40 on FO B cells being a costimulatory promoter of atherosclerosis; reductions in IgG, spleen germinal B cell, and plasma cell numbers were also less than with MHCII deletion. A recent report has shown that marginal-zone B cells reduce atherosclerosis by mediating Tfh cell development to limiting adaptive immune responses. 57 It is well known that marginal-zone B cells reside both within the marginal zone and follicles. 58 In follicles they present antigens to follicular dendritic cells. 59, 60 Collectively, marginal-zone B cells exert both positive and inhibitory effects. Our results tend to suggest that the overall effect of the transient increase in spleen is at best small, based on effects on atherosclerotic lesions 4 weeks after commencing the HFD, where effects on lesions are similar 4 and 8 weeks after commencing the HFD.
Although it is possible that MHCII and CD40 expression by FO B cells contribute to atherosclerosis by mechanisms involving CD4 + T cell activation 61 and increased effector cytokine responses, 62 a common feature of B cell-specific deficiencies in either MHCII or CD40 was the reduction in serum IgG levels. To determine its importance for atherosclerosis, we deleted Blimp-1 in B cells. We used CD23-CRE to specifically delete Blimp-1 from B cells. CD23 is upregulated at the T2 stage of B cell development, and this results in CRE-mediated deletion of Blimp-1 from FO and marginal-zone B cells, as well as most B1 cells. 63, 64 This accounts for the large reductions in plasma IgG as well as IgM in mixed chimeric Ldlr Despite associations between circulating immunoglobulins and atherosclerosis being described for >20 years, 16, 17 direct proof for a pathogenic role for immunoglobulins is still lacking. Immunoglobulins associated with increased atherosclerosis include IgE, 65 IgA, 66 and IgG, 67 while IgM is generally associated with protection. 4, 67 In mixed chimeric mice with targeted depletion of MHCII or CD40, we observed the depletion of these molecules in B1a cells (data not shown), and similar finding has been reported in conditional knockout mouse model to delete MHCII on B cells. 68 The finding that selective deficiency of MHCII and CD40 on B cells does not affect plasma IgM in contrast to the fact that IgM levels plummet down in B cell-selective Blimp-1 deficiency supports that B1a cells, major natural IgM producer in innate-like responses, do not require MHCII and CD40, but Blimp-1 in their secretion of natural antibodies in accordance with literature. 69 It is also important to note that regulatory B cells are heterogeneous in nature, and some of them express neither CD23 nor Blimp-1 for their differentiation/suppressor function. 70, 71 Furthermore, activated peritoneal cavity B-1a cells also regulate immune responses by secreting IL-10. 72 We have assessed and found that CD19 + CD5
+ B1a cells ( Figure 3A ) and B220 This cytokine-mediated pathway contributes no >20% to lesion development, 10 and the remainder can be accounted for by IgGdependent mechanisms described in this article. The transferred IgGs accumulated in atherosclerotic lesions, suggesting that they bind avidly to specific-yet-to-be-defined antigens within developing lesions, contrasting with IgGs from nonatherosclerotic mice which are barely detectable in lesions. The transferred IgGs not only promote progression of atherosclerotic lesions but also affect lesion characteristics, increasing apoptosis/necrotic core size and lesion inflammatory molecules, effects that can be attributed to initial binding of the IgGs to specific target antigens and activation of the complement pathway and cytotoxic immune cells through activation of FcγRs.
The transfer of IgG most likely promoted apoptosis and necrotic core development possibly via NK cell-mediated antibody-dependent cellular cytotoxicity. 76 In this study, we did not specifically study NK cells; they are known to promote necrotic core development in lesions. 77 The process of IgG isolation (extensive wash before eluting IgG from affinity column) prevents a possible contamination of proinflammatory cytokines, and IgGs purified are heterogeneous. Of the major proinflammatory cytokines IL-1α, IL-6, TNF-α, and IL-1β, only IL-1α and IL-6 were shown to bind to IgG purified via ion-exchange chromatography. 78 As both cytokines were not detected in affinity-purified IgG and the plasma half-life of IL-1α and IL-6 in rodents (rats, shorter in mice) is ≈2.5 79 and 3 minutes, 80 respectively, they are extremely unlikely to account for any of the observed IgG effects on atherosclerotic lesions. AntigenIgG immune complexes accumulated in atherosclerotic lesion can activate NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) activation in lesion-dominant macrophages through Fcγ receptors for macrophage-derived IL-1β and TNF-α production. 81, 82 TNF-α and IL-1β can upregulate both RANTES and MCP-1 through NF-κB activation in an autocrine manner 83, 84 and induce apoptosis. 85 Although we have demonstrated that IgGs from atherosclerotic mice promote atherosclerosis, the specific antigens targeted remain to be identified. Although not specifically studied, our findings that IgG from atherosclerotic mice greatly increase lesion inflammation by increasing expression of proinflammatory cytokines TNF-α and IL-1β and chemokines MCP-1 and RANTES suggest initiation of a complex sterile inflammatory response mediated by release of DAMPs (damage-associated molecular patterns) such as HMGB1 from necrotic cells 47 and activation of the Nlrp3 (nucleotide-binding domain and leucine-rich repeat containing [NLR] protein 3) inflammasome. 52 HMGB1 enhances atherosclerosis development 49 and increases TNF-α and IL-1β expression, 49, 86 which may be responsible for the observed elevations in chemokines. 87, 88 Among major IgG subclasses, IgG1 is the most abundant subclass induced by soluble and membrane protein antigens, and IgG2 and IgG3 are potent responders to pathogens, with IgG4 being a dominant subclass to allergens. 89 Limitation on current methodology prevents purification of individual IgG subclasses to study their specific roles in atherosclerosis.
In summary, we provide direct evidence that the major mechanism by which FO B cells promote atherosclerosis involves their differentiation to plasma cells. The atherogenic effects of FO B cells are highly dependent on their expression of MHCII, CD40, and Blimp-1. Furthermore, our findings that IgG isolated from atherosclerotic mice greatly promote atherosclerosis confirm their pathogenicity and together with deletion studies indicate that pathogenic IgGs are important contributors to the atherogenic effects of FO B cells. Recently, stable cyclic antibody neutralizing peptides have been developed to specifically target pathogenic antibodies such as those activating cardiac β-1 adrenoceptors. 90 Our study raises the possibility that such approaches may be therapeutically useful to also inhibit the atherogenic effects of B cells without compromising the immune system.
